Anti-MAG First Administration to Human

Clinical trial NCT00622609 · COMPLETED

Trial details

NCT number: NCT00622609
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cerebrovascular Accident

Start date: 2007-08-01
Primary completion: 2009-04-09
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.